| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/27/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 1000 | $166.18 | $166.2k | | 09/27/2023 |
| 09/27/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 1000 | $221.88 | $221.9k | | 09/27/2023 |
| 09/27/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 1000 | $189.98 | $190k | | 09/27/2023 |
| 09/27/2023 | Robie Robert J. | EVP, Institutional Buyside | Sale | Common Stock | 3k | $431.34 | $1.3M | | 09/27/2023 |
| 08/01/2023 | Moskoff Gregory T | MD,Controller and CAO | Payment of Exercise | Common Stock | 7 | $433.59 | $3k | | 08/01/2023 |
| 08/01/2023 | Harding Catrina | Chief People Officer | Grant | Common Stock | 1.5k | $0.00 | $0 | | 08/01/2023 |
| 05/05/2023 | Reeve Jonathan | EVP, Head of CTS | Sale | Common Stock | 670 | $404.75 | $271.2k | | 09/15/2022 |
| 05/05/2023 | Reeve Jonathan | EVP, Head of CTS | Sale | Common Stock | 112.9371 | $405.24 | $45.8k | | 09/15/2022 |
| 05/05/2023 | Reeve Jonathan | EVP, Head of CTS | Exercise | Non-Qualified Stock Option (right to buy) | 670 | $269.43 | $180.5k | | 09/15/2022 |
| 04/03/2023 | Stepp Katherine M | Chief Technology Officer (CTO) | Sale | Common Stock | 297 | $417.58 | $124k | | 04/03/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Sale | Common Stock | 900 | $410.86 | $369.8k | | 03/31/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Sale | Common Stock | 1.5k | $413.23 | $602.1k | | 03/31/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Sale | Common Stock | 100 | $412.06 | $41.2k | | 03/31/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 607 | $152.28 | $92.4k | | 03/31/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 850 | $166.18 | $141.3k | | 03/31/2023 |
| 03/31/2023 | Robie Robert J. | EVP, Institutional Buyside | Exercise | Employee Stock Option (right to buy) | 1000 | $221.88 | $221.9k | | 03/31/2023 |
| 03/16/2023 | Reeve Jonathan | EVP, Head of CTS | Other (acquisition) | Common Stock | 0.4497 | $405.20 | $182.2 | | 09/15/2022 |
| 03/01/2023 | Snow Frederick Philip | CEO | Sale | Common Stock | 2k | $412.68 | $825.4k | | 03/01/2023 |
| 03/01/2023 | Snow Frederick Philip | CEO | Sale | Common Stock | 1000 | $413.38 | $413.4k | | 03/01/2023 |
| 03/01/2023 | Snow Frederick Philip | CEO | Exercise | Employee Stock Option (right to buy) | 3k | $164.90 | $494.7k | | 03/01/2023 |
| 02/28/2023 | Reeve Jonathan | EVP, Head of CTS | Other (acquisition) | Common Stock | 26.1964 | $352.37 | $9.2k | | 09/15/2022 |
| 01/17/2023 | Choy Siew Kai | Director | Grant | Non-Employee Director Stock Option (right to buy) | 815 | $428.70 | $349.4k | | 01/17/2023 |
| 01/17/2023 | Choy Siew Kai | Director | Grant | Common Stock | 247 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | Tejada Maria Teresa | Director | Grant | Common Stock | 384 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | Tejada Maria Teresa | Director | Grant | Non-Employee Director Stock Option (right to buy) | 1.3k | $428.70 | $543.6k | | 01/17/2023 |
| 01/17/2023 | SIEGEL LAURIE | Director | Grant | Common Stock | 247 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | SIEGEL LAURIE | Director | Grant | Non-Employee Director Stock Option (right to buy) | 815 | $428.70 | $349.4k | | 01/17/2023 |
| 01/17/2023 | ABRAMS ROBIN ANN | Director | Grant | Common Stock | 176 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | ABRAMS ROBIN ANN | Director | Grant | Non-Employee Director Stock Option (right to buy) | 583 | $428.70 | $249.9k | | 01/17/2023 |
| 01/17/2023 | MCGONIGLE JAMES J | Director | Grant | Common Stock | 176 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | MCGONIGLE JAMES J | Director | Grant | Non-Employee Director Stock Option (right to buy) | 583 | $428.70 | $249.9k | | 01/17/2023 |
| 01/17/2023 | Shavel Lee | Director | Grant | Common Stock | 247 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | Shavel Lee | Director | Grant | Non-Employee Director Stock Option (right to buy) | 815 | $428.70 | $349.4k | | 01/17/2023 |
| 01/17/2023 | Frank Malcolm | Director | Grant | Common Stock | 176 | $0.00 | $0 | | 01/17/2023 |
| 01/17/2023 | Frank Malcolm | Director | Grant | Non-Employee Director Stock Option (right to buy) | 583 | $428.70 | $249.9k | | 01/17/2023 |
|